Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Sunday, November 22, 2009 12:06 AM

Published 11/03/2009 by RTTNews.com


Pfizer, Medivation Initiate Two Phase 3 Trials Of Dimebon In Alzheimer's Patients - Update

This Virtual Directory does not allow contents to be listed.

Share this 

What others report on the same story

Pfizer and Medivation initiate dimebon trials i...
Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational ... - [11/04/2009 - News-Medical.Net]
Pfizer And Medivation Initiate Two Phase 3 Tria...
(BusinessWire) Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of CONTACT and CONSTELLATION, two Phase 3 ... - [11/03/2009 - Individual.com]

Related Stories

First Reported 11/09/2009 - Updated 11/10/2009 - 37 Documents
Wyeth Ltd - Click to view image in its original context
Wyeth Ltd
Pfizer will shut down six research-and-development sites in the U.S. and the U.K. as it streamlines R&D operations under a merger with Wyeth. The move will result in job cuts, including 600 employees at Pfizer's facility in St. Louis.St. Louis Post-Dispatch| ... [SmartBrief - 11/10/2009]
First Reported 11/09/2009 - Updated 11/10/2009 - 12 Documents (in Biotechnology)
Monsanto Company - Click to view image in its original context
Monsanto Company
Twenty-five years ago, fast-growing Monsanto Co. christened a new research campus in Chesterfield.On Monday, a reincarnation of the same company reclaimed the property for $435 million.Monsanto's plans to buy the Chesterfield Village Research Center from ... [Individual.com - 11/10/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 6 Documents (in Health)
The boss of the new HIV company set up by GlaxoSmithKline and Pfizer has said it will be "up to the shareholders" to decide whether the business eventually spins off and floats. By Graham Ruddick Published: 7:14PM GMT 03 Nov 2009 ViiV Healthcare, which ... [Telegraph - 11/03/2009]
Entities: HIV/AIDS, Pfizer Inc, Limet, IPO
First Reported 11/05/2009 - Updated 11/05/2009 - 6 Documents (in Medicine)
GlaxoSmithKline plc - Click to view image in its original context
GlaxoSmithKline plc
The specialist HIV company set up by GlaxoSmithKline and Pfizer has been officially launched as ViiV Healthcare.Dominique Limet, ViiV Healthcare’s chief executive officer, set out the company’s priorities in a statement released earlier this week (3 November ... [PJ Online - 11/05/2009]
First Reported 11/10/2009 - Updated 11/10/2009 - 4 Documents
(RTTNews) - Tuesday, Pfizer China, a unit of drug maker Pfizer Inc (PFE: News ), said it entered into a partnership with China's BMP Sunstone Corp. (BJGP) to exclusively import, distribute and promote Depo-Provera or Medroxy-progesterone Acetate, a Pfizer ... [RTTNews.com - 11/10/2009]
First Reported 11/04/2009 - Updated 11/04/2009 - 3 Documents (in Health)
UBS AG - Click to view image in its original context
UBS AG
The joint venture between , Viiv, has officially opened up for business as a powerhouse developer of new HIV therapies. But analysts are wondering if Viiv has more to do with getting the two pharma giants out of the controversial therapeutic area than ... [FierceBiotech - 11/04/2009]
First Reported 11/04/2009 - Updated 11/05/2009 - 3 Documents
Pfizer Inc - Click to view image in its original context
Pfizer Inc
SAN DIEGO (Nov. 5) More smokers with chronic obstructive pulmonary disease quit smoking using an anti-smoking drug from Pfizer than those taking placebo, according to results of a recent study.The 12-week study, presented at the annual scientific assembly ... [Drug Store News - 11/05/2009]
First Reported 10/29/2009 - Updated 10/29/2009 - 1 Documents (in Internet & IT)
The Pfizer headquarters in New York City. Foreign pharmaceutical firms including Pfizer agreed to accept Ecuador's decision to bypass patents on 2,000 drugs in order to produce them locally or buy cheaper versions elsewhere. ... [Yahoo! Malaysia - 10/29/2009]
Entities: Ecuador, Patent, Pfizer Inc
First Reported 11/04/2009 - Updated 11/04/2009 - 1 Documents (in Corporate Deals)
Merck & Co. led drug stocks higher early Wednesday, as the pharmaceutical giant marked the first day since the closure of its $41 billion merger with rival Schering-Plough Corp.The NYSE Arca Pharmaceutical Index rose 0.5% to 286.64, and the NYSE Arca ... [MarketWatch - 11/04/2009]
In Focus
Network

Blogs

sort by: Date | Relevance
Pfizer's New Layout [Corante - 11/10/2009]
The company has issued a press release detailed which sites are staying, and which are leaving: Pfizer will have five main research sites that will serve as central ...
Pfizer, Then and Now: Shareholder Say On Execut... [WSJ.com: Health Blog - 10/30/2009]
Pfizer shareholders will get to cast a non-binding “advisory vote” on the company’s compensation packages for senior execs. In its press release announcing the news ...
Another Look at Pfizer's Recent Moves [Healthcare Sector and Stocks Analysis from Seek ... - 11/10/2009]
Derek Lowe submits: Pharmaconduct.org has another look at Pfizer's (PFE) announcement Monday, and tries to address some of the many unanswered questions left open ...
Pfizer's Site Closures - An Analysis [In the Pipeline - 11/10/2009]
Pharmaconduct.org has another look at Pfizer's announcement yesterday, and tries to address some of the many unanswered questions left open by the company's press ...
Pfizer slashing R&D footprint by 35% [The Deal.com - 11/10/2009]
Pfizer Inc. (NYSE:PFE) employees concerned about their jobs may have a better idea of where they stand. The pharmaceutical giant on Monday announced plans to consolidate ...
1 2 3 4 5 6

Audio/Video

sort by: Date | Relevance
Pfizer Broke Law by Promoting Drugs for Unappro... [Bloomberg - YouTube - 11/09/2009]
1

  •  
  •  
  •